Related Experiment Video

Updated: May 9, 2026

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis
07:42

Laser-capture Microdissection of Human Prostatic Epithelium for RNA Analysis

Published on: November 26, 2015

Down-regulation and aberrant cytoplasmic expression of GLTSCR2 in prostatic adenocarcinomas

Jee-Youn Kim1, Young-Eun Cho, Gou Young Kim

  • 1Department of Pathology, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea.

Cancer Letters
|August 8, 2013
PubMed

Insights

Glial tumor suppressor candidate 2 (GLTSCR2) is suppressed in prostate cancer, with its reduced expression linked to higher Gleason scores. This suggests GLTSCR2 acts as a tumor suppressor in prostate adenocarcinoma development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Glial tumor suppressor candidate 2 (GLTSCR2) is a nuclear/nucleolar protein implicated in human cancers.
  • Previous studies indicate GLTSCR2 is suppressed and mutated in various human cancers.
  • The role of GLTSCR2 in prostate cancer development and progression remains largely unexplored.

Purpose of the Study:

  • To investigate the pathological significance of GLTSCR2 downregulation and cytoplasmic expression in prostate cancer.
  • To determine the association between GLTSCR2 expression levels and clinicopathological features, such as Gleason's score.
  • To elucidate the pathogenetic mechanisms underlying GLTSCR2 alterations in prostate cancer.

Main Methods:

  • Analysis of GLTSCR2 expression in prostate cancer tissues and adjacent normal tissues.
  • Correlation of GLTSCR2 expression with Gleason's scores and other clinicopathological parameters.
  • Investigation of molecular mechanisms driving GLTSCR2 downregulation and cytoplasmic translocation.

Main Results:

  • GLTSCR2 expression is significantly suppressed in prostate cancers compared to normal tissues.
  • Reduced GLTSCR2 expression and cytoplasmic localization are associated with higher Gleason's scores.
  • The study identified pathogenetic mechanisms contributing to GLTSCR2 suppression and altered localization.

Conclusions:

  • GLTSCR2 functions as a tumor suppressor in prostatic adenocarcinomas.
  • Downregulation and cytoplasmic expression of GLTSCR2 are significant indicators of prostate cancer progression.
  • Targeting GLTSCR2 may offer a potential therapeutic strategy for prostate cancer.
Keywords:
GLTSCR2Prostatic adenocarcinomaTumor suppressor

More Related Videos

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)08:30

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)

Published on: May 16, 2012

miRNA Expression Analyses in Prostate Cancer Clinical Tissues11:29

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

Related Concept Videos

GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...